Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative

Many cancer types are serious diseases causing mortality, and new therapeutics with improved efficacy and safety are required. Immuno-(cell)-therapy is considered as one of the promising therapeutic strategies for curing intractable cancer. In this study, we tested R2016, a newly developed heterocyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Keum-joo, Choi, Ki ryung, Ryu, Chung-Kyu, Lee, Seog Jae, Kim, Ho Jeong, Lee, Hyunah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345761/
https://www.ncbi.nlm.nih.gov/pubmed/28282460
http://dx.doi.org/10.1371/journal.pone.0173121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345761/
https://www.ncbi.nlm.nih.gov/pubmed/28282460
http://dx.doi.org/10.1371/journal.pone.0173121

Ejemplares similares